ICU-acquired bloodstream infections in critically ill patients with COVID-19

Abstract

Listen

Translate article

In the context of the COVID-19 pandemic, information concerning secondary infections is thus far scarce and variable. While a low rate has been reported in patients with COVID-19 during hospitalization [1], this proportion increases in studies including intensive care unit (ICU) patients [2]. Furthermore, admission to ICUs with increased antimicrobial resistance is of concern. We investigated the incidence, aetiology and impact of ICU-acquired infections in COVID-19 patients admitted to an ICU with a known burden of multi-drug resistance [3].